Select Page

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

Press Release

Sun Pharmaceuticals announces approval of Winlevi® in Australia

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

SunPharma on Twitter

Our Global Clinical Operations team recently convened in Agra, India. It was a dynamic gathering uniting experts from India, Japan, and the USA. Together, we explored innovative strategies and insights aimed at achieving excellence in clinical operations.



Sun's 'Recycle to Rekindle' initiative: Over 10 days, 770 kgs of old clothing was transformed into rugs.

These rugs were distributed among specially-abled children, tribal schools, underprivileged communities and senior citizens in remote villages across Maharashtra.



It's been 40 years of Sun Reaching People and Touching Lives. Present in 100+ countries with a dedicated team of over 41,000 employees, we are driven by our core values of quality, reliability, innovation, trust, & consistency.

#40UnderTheSun #ReachingPeopleTouchingLives

Our Emerging Markets' Global Marketing Meet 2024 brought together marketing team members from 16 countries across Latin America, Africa, Middle East and Asia Pacific regions. Spread over 5 days, it fostered the exchange of ideas, insights, and collaboration among the attendees!


We are pleased to announce that Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for Winlevi® (clascoterone cream 1%), indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
Read more :

Here's Lorraine Thanicatt warmly reflecting on her rewarding journey of two decades with Sun & how it has nurtured her growth and learning. What she values the most is the empowering culture, offering the freedom to innovate, make decisions & learn from them.


Through Sun Pharma Science Foundation’s research fellowship, we empower upcoming scientists by offering them the support they require to conduct their approved research projects. These are the top 3 scientists selected by our jury for the 2023 Research Fellowship Programme.

Load More

Find out more


Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.


Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.


We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.


Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue